Lanthanide-doped hollow nanomaterials as theranostic agents

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 6, Issue 1, 2014, Pages 80-101

  Kang, Xiaojiao ^a   Li, Chunxia ^a   Cheng, Ziyong ^a   Ma, Ping'an ^a   Hou, Zhiyao ^a   Lin, Jun ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PARAMAGNETIC PROPERTIES; PERSONALIZED MEDICINES; REAL TIME MONITORING; STORAGE AND DELIVERY; SYNTHETIC PROCEDURES; TARGETED DRUG DELIVERY; THERAPEUTIC APPLICATION; THERAPEUTIC FUNCTIONS;

DIAGNOSIS; DRUG DELIVERY; FLUORESCENCE; MAGNETIC RESONANCE IMAGING; NANOCOMPOSITES;

RARE EARTH ELEMENTS;

ALUMINUM OXIDE; CERIUM; CETRIMIDE; DOXORUBICIN; DYSPROSIUM; EUROPIUM; FLUORIDE; GADOLINIUM; HEXANOL; HOLMIUM; HYDROXIDE; INDOMETACIN; LANTHANIDE; LANTHANIDE DOPED HOLLOW NANOMATERIAL; LANTHANUM; LUTETIUM; NANOCOMPOSITE; NANOMATERIAL; NEODYMIUM; OXIDE; PHOSPHATE; POLYACRYLIC ACID; PRASEODYMIUM; PROMETHIUM; SAMARIUM; SCANDIUM; TERBIUM; THULIUM; UNCLASSIFIED DRUG; VANADIC ACID; YTTERBIUM;

CANCER THERAPY; DIAGNOSTIC IMAGING; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EARLY DIAGNOSIS; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; GENE TARGETING; HOLLOW FIBER; HUMAN; HYDROLYSIS; IMAGING; INCUBATION TIME; INTERDISCIPLINARY RESEARCH; IONIC STRENGTH; LUMINESCENCE; MEDICAL PROCEDURES; MICELLE; MICROWAVE IRRADIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALIZED MEDICINE; PHOTOLUMINESCENCE; POSITRON EMISSION TOMOGRAPHY; PRECIPITATION; PRIORITY JOURNAL; RADIOSENSITIZATION; REACTION TIME; REVIEW; SYNTHESIS;

ANIMALS; DRUG DELIVERY SYSTEMS; HELA CELLS; HUMANS; LANTHANOID SERIES ELEMENTS; MICE; NANOMEDICINE; NANOSTRUCTURES;

EID: 84890172000     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1251     Document Type: Review

References (81)

1. Yan ZG, Yan CH. Controlled synthesis of rare earth nanostructures. J Mater Chem 2008, 18:5046-5059.
2. Bünzli JC. Lanthanide luminescence for biomedical analyses and imaging. Chem Rev 2010, 110:2729-2755.
3. Liu YL, Ai KL, Liu JH, Yuan QH, He YY, Lu LH. A high-performance ytterbium-based nanoparticulate contrast agent for in vivo X-ray computed tomography imaging. Angew Chem Int Ed 2012, 51:1437-1442.
4. 3+-doped nanoparticles for upconversion and magnetic resonance imaging: some critical notes on recent progress and some aspects to be considered. Nanoscale 2012, 4:7309-7321.
5. Kelkar SS, Reineke TM. Theranostics: combing imaging and therapy. Bioconjugate Chem 2011, 22:1879-1903.
6. Terreno E, Uggeri F, Aime S. Image guided therapy: the advent of theranostic agents. J Control Release 2012, 161:328-337.
7. Santra S, Malhotra A. Fluorescent nanoparticle probes for imaging of cancer. WIREs Nanomed Nanobiotechnol 2011, 3:501-510.
8. Arruebo M. Drug delivery from structured porous inorganic materials. WIREs Nanomed Nanobiotechnol 2012, 4:16-30.
9. Hu J, Chen M, Fang XS, Wu LM. Fabrication and application of inorganic hollow spheres. Chem Soc Rev 2011, 40:5472-5491.
10. Van Vleck JH. The puzzle of rare-earth spectra in solids. J Phys Chem 1937, 41:67-80.
11. Liu YS, Tu DT, Zhu HM, Chen XY. Lanthanide-doped luminescent nanoprobes: controlled synthesis, optical spectroscopy, and bioapplications. Chem Soc Rev 2013, 42:6924-6958.
12. Wang F, Liu XG. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem Soc Rev 2009, 38:976-989.
13. 2 MRI contrast agents. Phys Chem Chem Phys 2012, 14:12687-12700.
14. Binnemans K. Lanthanide-based luminescent hybrid materials. Chem Rev 2009, 109:4283-4374.
15. Blasse G, Grabmaier BC. Luminescent Materials. Berlin: Spinger-Verlag; 1994.
16. Liu YS, Tu DT, Zhu HM, Ma E, Chen XY. Lanthanide-doped luminescent nano-bioprobes: from fundamentals to biodetection. Nanoscale 2013, 5:1369-1384.
17. Haase M, Schäfer H. Upconverting nanoparticles. Angew Chem Int Ed 2011, 50:2-24.
18. 3+) spheres: facile synthesis and luminescent properties. Inorg Chem 2011, 50:2182-2190.
19. Dong L, An D, Gong M, Lu Y, Gao HL, Xu YJ, Yu SH. PEGylated upconverting luminescent hollow nanospheres for drug delivery and in vivo imaging. Small 2013, 9:3235-3241.
20. 3+) spheres via a sacrificial template method. CrystEngComm 2010, 12:3717-3723.
21. 3:Ln (Ln = Yb/Er, Yb/Ho) microspheres. Langmuir 2011, 27:5616-5623.
22. 3:Eu hollow microspheres. Cryst Growth Des 2009, 9:301-307.
23. 3 hollow spheres with upconversion luminescence, magnetic resonance, and drug delivery properties. J Phys Chem C 2011, 115:23790-23796.
24. 3+ microspheres with tunable up-conversion luminescence properties. RSC Adv 2013, 3:8407-8416.
25. Park J-U, Lee HJ, Cho W, Jo C, Oh M. Facile synthetic route for thickness and composition tunable hollow metal oxide spheres from silica-templated coordination polymers. Adv Mater 2011, 23:3161-3164.
26. 3 hollow microspheres: template-directed synthesis and luminescence properties. Langmuir 2010, 26:5122-5128.
27. Zhang F, Zhao DY. Fabrication of ordered magnetite-doped rare earth fluoride nanotube arrays by nanocrystal self-assembly. Nano Res 2009, 2:292-305.
28. 2 hollow nanoshells: two-photon imaging of cell binding. Chem Mater 2012, 24:4222-4230.
29. Fortes LM, Li YG, Réfega R, Goncalves MC. Up-conversion in rare earth-doped silica hollow spheres. Opt Mater 2012, 34:1440-1446.
30. 3+ (Ln = Eu, Er, Tb) luminescent hollow microspheres. CrystEngComm 2010, 12:2943-2948.
31. 3 nanotube arrays through a facile sol-gel template approach. J Am Chem Soc 2004, 126:5976-5977.
32. 3+ (Ln = Tm, Ho, Tm/Ho) microspheres: tunable up-conversion emissions and application as drug carriers. J Mater Chem B 2013, 1:2056-2065.
33. Hou SY, Xing Y, Liu XC, Zou YC, Liu B, Sun XJ. Barium fluoride hollow microcubes: hydrothermal synthesis and host for lanthanide near-infrared luminescent properties. CrysEngComm 2010, 12:1945-1948.
34. 3 nanotube and its use as a drug-carrying vehicle. Acta Biomater 2010, 6:3713-3719.
35. 3 hollow spheres and fine-tuning of its outer diameter and cavity size. Small 2010, 6:1886-1891.
36. 3 hollow nanospheres for high performance lithium-ion rechargeable batteries. Chem Commun 2010, 48:3200-3202.
37. 4:Tb, Gd hollow nanospheres as peroxidase mimic and magnetic-fluorescent imaging agent. Chem Commun 2012, 48:6839-6841.
38. Yada M, Mihara M, Mouri S, Kuroki M, Kijima T. Rare earth (Er, Tm, Yb, Lu) oxide nanotubes templated by dodecylsulfate assemblies. Adv Mater 2002, 14:309-313.
39. 3+ hollow nanospheres: formation mechanism and upconversion luminescence. Eur J Inorg Chem 2010, 12:1813-1819.
40. 3+ hollow spheres as efficient luminescent materials and smart drug carriers. Chem Eur J 2010, 16:5672-5680.
41. Fang YP, Xu AW, You LP, Song RQ, Yu JC, Zhang HX, Li Q, Liu HQ. Hydrothermal synthesis of rare earth (Tb, Y) hydroxide and oxide nanotubes. Adv Funct Mater 2003, 13:955-960.
42. Wang X, Li Y. Fullerene-like rare-earth nanoparticles. Angew Chem Int Ed 2003, 42:3497-3500.
43. Liang X, Xu B, Kuang SM, Wang X. Multi-functionalized inorganic-organic rare earth hybrid microcapsules. Adv Mater 2008, 20:3739-3744.
44. 3 hollow nanoparticles. Mater Lett 2007, 61:2765-2768.
45. 3+ hollow spheres-hydrothermal synthesis, luminescence and drug-delivery properties. J Mater Chem 2011, 21:3686-3694.
46. 3+ hollow spheres as drug carriers. Biomaterials 2011, 32:4161-4173.
47. 3+ hierarchical hollow spheres. Inorg Chem 2010, 49:3305-3309.
48. 3+ nanospheres as anticancer drug carrier and MRI contrast agent. Langmuir 2013, 29:1286-1294.
49. 3+ hierarchical hollow spheres with tunable textual parameters and luminescent properties. Dalton Trans 2013, 42:3986-3993.
50. 3 hollow spheres via one step chemical conversion. Mater Chem Phys 2011, 129:161-167.
51. 3+ hollow nanofibers via the combination of electrospinning with fluorination technique. J Fluorine Chem 2013, 145:70-76.
52. 3] parents. ACS Nano 2009, 3:159-164.
53. Zhang F, Shi YF, Sun XH, Zhao DY, Stucky GD. Formation of hollow upconversion rare-earth fluoride nanospheres: nanoscale Kirkendall effect during ion exchange. Chem Mater 2009, 21:5237-5243.
54. 3+ nanospheres for cell imaging and targeted anti-cancer drug delivery. Biomaterials 2013, 34:1601-1612.
55. 4:Yb, Er nanocrystal monolayer by electron-beam lithography. Small 2009, 5:2057-2060.
56. 4 upconversion nanoparticles for in vitro cell imaging and drug delivery. Chem Eur J 2013, 19:2685-2694.
57. 2 hollow spheres. RSC Adv 2013, 3:3544-3547.
58. Cui F, Zhang JH, Cui TY, Liang S, Ming L, Gao ZM, Yang B. A facile solution-phase approach to the synthesis of luminescent europium methacrylate nanowires and their thermal conversion into europium oxide nanotubes. Nanotechnology 2008, 19:065607.
59. 3 in hollow nanoparticle structures by controlled chemical etching with poly(acrylic acid). RSC Adv 2013, 3:16374-16379.
60. 4 (RE = Yb, Gd, Y) hollow microspheres covered with nanothorns as affinity probes for selectively capturing and labeling phosphopeptides. Chem Eur J 2012, 18:2014-2020.
61. Li ZH, Tao Y, Huang S, Gao N, Ren JS, Qu XG. Lanthanide-based hollow mesoporous nanoparticles: a novel multifunctional platform for simultaneous gene delivery and cell imaging. Chem Commun 2013, 49:7129-7131.
62. 2 nanotubes for anti-cancer drug delivery and dual modal imaging. RSC Adv 2013, 3:8517-8526.
63. 3 particles. Chem Mater 2008, 20:3840-3848.
64. 3/C nanoshells for MR imaging and NIR therapeutic applications. Adv Funct Mater 2009, 19:249-258.
65. 2 nanocapsules as carriers for drug delivery. Dalton Trans 2011, 40:12818-12825.
66. 3 nanoparticle-functionalized hollow silica nanospheres based on the spontaneous formation and decomposition of a cross-linked organic/inorganic hybrid core. Chem Commun 2011, 47:6329-6331.
67. 4 hollow spheres for up-conversion cell imaging, MRI and pH-dependent drug release. Nanoscale 2013, 5:253-261.
68. Sami H, Maparu AK, Kumar A, Sivakumar S. Generic delivery of payload of nanoparticles intracellularly via hybrid polymer capsules for bioimaging applications. PLoS ONE 2012, 7:e36195.
69. 3+-poly(acrylic acid) hybrid microspheres. Biomaterials 2012, 33:2583-2592.
70. Chen HY, Moore T, Qi B, Colvin DC, Jelen EK, Hitchcock DA, He J, Mefford OT, Gore JC, Alexis F, et al. Monitoring pH-triggered drug release from radioluminescent nanocapsules with X-ray excited optical luminescence. ACS Nano 2013, 7:1178-1187.
71. Chen M, Xie L, Li FY, Zhou SX, Wu LM. Capillary-force-induced formation of luminescent polystyrene/(rare-earth-doped nanoparticle) hybrid hollow spheres. ACS Appl Mater Interfaces 2010, 2:2733-2737.
72. Mei X, Chen DY, Li NJ, Xu QF, Ge JF, Li H, Yang BX, Xu YJ, Lu JM. Facile preparation of coating fluorescent hollow mesoporous silica nanoparticles with pH-sensitive amphiphilic diblock copolymer for controlled drug release and cell imaging. Soft Matter 2012, 8:5309-5316.
73. Zhang LY, Wang TT, Yang L, Liu C, Wang CG, Liu HY, Wang A, Su ZM. General route to multifunctional uniform yolk/mesoporous silica shell nanocapsules: a platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Chem Eur J 2012, 18:12512-12521.
74. Fan WP, Shen B, Bu WB, Chen F, Zhao KL, Zhang SJ, Zhou LP, Peng WJ, Xiao QF, Xing HY, et al. Rattle-structured multifunctional nanotheranostics for synergetic chem-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging. J Am Chem Soc 2013, 135:6494-6503.
75. Liu HY, Wang TT, Zhang LY, Li L, Wang A, Wang CG, Su ZM. Selected-control fabrication of multifunctional fluorescent-magnetic core-shell and yolk-shell hybrid nanostructures. Chem Eur J 2012, 18:3745-3752.
76. 4:Yb, Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 2012, 33:4618-4627.
77. Zhang F, Braun GB, Pallaoro A, Zhang YC, Shi YF, Cui DX, Moskovits M, Zhao DY, Stucky GD. Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. Nano Lett 2012, 12:61-67.
78. 3+ rare earth oxide hollow sub-microspheres with encapsulated gold nanoparticles and their optical properties. Solid State Sci 2009, 11:96-101.
79. Kang XJ, Cheng ZY, Yang DM, Ma PA, Shang MM, Peng C, Dai YL, Lin J. Design and synthesis of multifunctional drug carriers based on luminescent rattle-type mesoporous silica microspheres with a thermosensitive hydrogel as a controlled switch. Adv Funct Mater 2012, 22:1470-1481.
80. 3+-loaded mesoporous silica composites for the Immobilization and release of lysozyme. Eur J Inorg Chem 2010, 2010:2655-2662.
81. Landsiedel R, Ma-Hock L, Haussmann H-J, van Ravenzwaay B, Kayser M, Wiench K. Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. WIREs Nanomed Nanobiotechnol 2012, 4:399-413.